Doyle Mittie sold AVTX
December 10, 2025 · Form 4 insider transaction
Doyle Mittie sold 1,013 shares of Avalo Therapeutics, Inc. at $4.10 per share, a transaction worth $4.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,013
Price
$4.10
Total value
$4.2K
InsiderDoyle Mittie
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateDecember 10, 2025
Filing dateDecember 12, 2025
Shares owned after3,622
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 3,622 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.